-
Loading metrics
Two snakebite antivenoms have potential to reduce Eswatini’s dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing
-
Stefanie K. Menzies ,
Roles Data curation, Formal analysis, Investigation, Writing – original draft, Writing – review & editing
* E-mail: Stefanie.Menzies@lstmed.ac.uk
Affiliations Centre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine, Liverpool, United Kingdom, Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, United Kingdom
⨯ - Thea Litschka-Koen,
- Rebecca J. Edge,
- Jaffer Alsolaiss,
- Edouard Crittenden,
- Steven R. Hall,
- Adam Westhorpe,
- Brent Thomas,
- James Murray,
- Nondusimo Shongwe,
- Sara Padidar,
- David G. Lalloo,
- Nicholas R. Casewell,
- Jonathan Pons,
- Robert A. Harrison
https://orcid.org/0000-0002-9273-9296
Two snakebite antivenoms have potential to reduce Eswatini’s dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing
- Stefanie K. Menzies,
- Thea Litschka-Koen,
- Rebecca J. Edge,
- Jaffer Alsolaiss,
- Edouard Crittenden,
- Steven R. Hall,
- Adam Westhorpe,
- Brent Thomas,
- James Murray,
- Nondusimo Shongwe
x
-
- Published: September 15, 2022
- https://doi.org/10.1371/journal.pntd.0010496